Medindia

X

Bird-Flu Vaccine to go for second round of testing on humans

by Savitha C Muppala on  September 2, 2006 at 4:44 PM Bird Flu News   - G J E 4
Bird-Flu Vaccine to go for second round of testing on humans
After the success of the first trial of the bird-flu vaccine on humans, China is all set to conduct the second trial for which it requires 400 volunteers. The second stage of the trial will focus on measuring the duration of protection afforded by the vaccine in the human body against the lethal H5N1 strain. It is required that the vaccine undergoes three phases of trial before being considered safe for administration.
Advertisement

In the first round, nearly 120 people got the vaccination shots, which did not trigger any adverse reaction, except for mild fever in few cases, an acceptable reaction to any vaccine.

Advertisement
The trial would require volunteers between the ages of 18 to 65, but people older than 65 or pregnant women will not be allowed to participate in the trial.

The vaccine developed by Sinovac Biotech Limited and the Ministry of Science and Technology and the Center for Disease Control and Prevention, has plans of enlarging the capacity of their production unit, to enable huge quantities of human bird-flu vaccine, after the envisaged two rounds of trials prove successful.



Source: Medindia
SAV
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All